Clinical Trials Search Results | Moffitt

Disease Site

Keyword

Study Type

Medication

Therapy

Principal Investigator

NCT#

Study Phase

1

2

3

4

27 Clinical Trials Found

Order By

Clinical Trial 23456

A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (CTN 2203)

Disease Site: Hodgkin's Lymphoma, Leukemia, other, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma

PI: Mirza, Sayeef

Clinical Trial 23363

Disease Site: Non-Hodgkin's Lymphoma

PI: Locke, Frederick

Clinical Trial 23331

Disease Site: Non-Hodgkin's Lymphoma

PI: Sandoval-Sus, Jose

Clinical Trial 21710

Disease Site: Non-Hodgkin's Lymphoma

PI: Gaballa, Sameh

Clinical Trial 21892

A Phase 2, Single-Arm, Open-Label Study using Oral JAK inhibition as Pre-Modulation in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Receiving CAR-T-Cell Therapy

Disease Site: Non-Hodgkin's Lymphoma

PI: Jain, Michael

Clinical Trial 23184

Disease Site: Non-Hodgkin's Lymphoma

PI: Locke, Frederick

Clinical Trial 22263

A Phase 1b Study of Oral AS-1763 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or B-cell Non-Hodgkin Lymphoma

Disease Site: Lymphoid Leukemia, Non-Hodgkin's Lymphoma, Soft Tissue

PI: Pinilla-Ibarz, Javier

Clinical Trial 23320

Disease Site: Non-Hodgkin's Lymphoma

PI: Lazaryan, Aleksandr

Clinical Trial 23489

Disease Site: Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma

PI: Jim, Heather

Clinical Trial 23502

Disease Site: Hodgkin's Lymphoma, Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Hematopoietic

PI: Jim, Heather

Clinical Trial 23570

Disease Site: Multiple Myeloma, Non-Hodgkin's Lymphoma

PI: Jim, Heather

Clinical Trial 20737

Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel That is Nonconforming for Commercial Release

Disease Site: Hodgkin's Lymphoma, Lymphoid Leukemia, Non-Hodgkin's Lymphoma

PI: Locke, Frederick